High Liner Foods (HLF) Q4 2024 earnings summary

Executive summary

• Achieved 8.7% year-over-year Adjusted EBITDA growth in Q4 2024, driven by retail volume gains and improved bottom-line performance despite volatile and highly competitive market conditions.

• Maintained strong free cash flow, generating $90.6 million for fiscal 2024, and strengthened the balance sheet by reducing net debt and increasing financial flexibility.

• Strategic investments in Norwegian aquaculture companies Norcod and Andfjord Salmon, totaling up to $10 million each, to reinforce industry position and diversify the portfolio.

• Continued innovation and diversification, including expansion into alternative species and value-added products.

• Experienced management team with a proven track record in acquisitions and integrations, focusing on sustainable protein solutions and growth in an underdeveloped category.

Financial highlights

• Q4 sales volume rose by 1.3% to 60.4 million lbs, driven by retail gains, especially in the club channel.

• Q4 sales decreased by $2.1 million (0.9%) to $235 million due to lower pricing, FX impact, and product mix, partially offset by higher volumes.

• Q4 gross profit increased by $2.3 million (4.7%) to $51 million; gross margin rose to 21.7%.

• Q4 Adjusted EBITDA grew by $1.9 million (8.7%) to $23.8 million; margin improved to 10.1%.

• FY2024 Adjusted EBITDA up 8.6% to $103.3 million; Adjusted EBITDA margin at 10.8%.

• FY2024 net income up 89.9% to $60.2 million, including $9.8 million litigation gain and $12.7 million debt modification gain; diluted EPS $1.89.

• Net debt at Q4 end was $233.2 million, down from $249.9 million a year earlier; Net Debt to Adjusted EBITDA improved to 2.3x.

• Capital expenditures were $23.8 million in 2024, up from $19 million in 2023.

Outlook and guidance

• Expects to profitably grow volume and Adjusted EBITDA in 2025, despite market volatility, consumer pullback, and inflationary tariffs.

• Anticipates low to mid single-digit volume growth for 2025, with profitability growth outpacing volume.

• Lent timing shift to Q2 will impact Q1 2025 results, but recovery expected in Q2.

• Raw material costs, especially for cod and haddock, expected to rise; company will manage costs and may pass on price increases.

• EBITDA margin target remains at or above 10%; leverage ratio expected to remain below long-term target of 3.0x barring major acquisitions.